The F.D.A. convened a panel of experts in September 2006 to review the safety of the drug, and the panel concluded that Trasylol should remain on the market.

• FDA于2006年9月召集了一个专家小组评价特雷西洛的安全性，最后结论认为，特雷西洛应该继续留在市场。